Beone Medicines Ltd. Class A · SSE:688235

Oyler John sold 64,628 Beone Medicines Ltd. Class A shares (Form 4)

Traded Jul 17, 2026 · Filed Jul 17, 2026

On Jul 17, 2026, Oyler John (Director, Chief Executive Officer) sold 64,628 Beone Medicines Ltd. Class A shares at an average US$312.00 for US$20.2M under a trading plan, leaving 0 shares. Filed Jul 17, 2026 (Form 4).

Sold
64,628 shares
Price
US$312.00 average (US$305.20 to US$315.06)
Value
US$20.2M
Holding after
0 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 17, 2026American Depositary SharesOption exercise64,628US$119.9664,628Direct
Jul 17, 2026American Depositary SharesSale1,440US$305.2063,188Direct
Jul 17, 2026American Depositary SharesSale597US$306.9662,591Direct
Jul 17, 2026American Depositary SharesSale680US$309.0561,911Direct
Jul 17, 2026American Depositary SharesSale4,833US$310.3757,078Direct
Jul 17, 2026American Depositary SharesSale5,543US$311.4251,535Direct
Jul 17, 2026American Depositary SharesSale35,829US$312.1715,706Direct
Jul 17, 2026American Depositary SharesSale14,915US$313.19791Direct
Jul 17, 2026American Depositary SharesSale740US$314.3251Direct
Jul 17, 2026American Depositary SharesSale51US$315.060Direct

Source

View original at SEC

Related